STRATA CRITICAL MEDICAL, INC. Cash and Restricted Cash
STRATA CRITICAL MEDICAL, INC. (SRTA) had Cash and Restricted Cash of $16.58 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-04
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $16.58M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $58.99M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $31.23M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $23.02M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $16.58M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $58.99M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $31.23M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $23.02M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $60.32M 10-Q · filed 2026-08-04 | |
| 2025-03-31 | $35.69M 10-Q · filed 2026-05-06 | |
| 2024-12-31 | $19.65M 10-Q · filed 2026-08-04 | |
| 2024-09-30 | $21.41M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $28.37M 10-Q · filed 2025-08-05 | |
| 2024-03-31 | $38.06M 10-Q · filed 2025-05-12 | |
| 2023-12-31 | $29.02M 10-K · filed 2026-03-03 | |
| 2023-09-30 | $38.27M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $39.39M 10-Q · filed 2024-08-08 | |
| 2023-03-31 | $43.82M 10-Q · filed 2024-05-07 | |
| 2022-12-31 | $44.42M 10-K · filed 2025-03-13 | |
| 2022-09-30 | $52.98M 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $188.25M 10-Q · filed 2023-08-09 | |
| 2022-03-31 | $4.18M 10-Q · filed 2023-05-11 | |
| 2021-12-31 | $3.23M 10-K · filed 2024-03-12 | |
| 2021-09-30 | $7.58M 10-K · filed 2023-03-16 | |
| 2021-06-30 | $30.63M 10-Q · filed 2022-08-09 | |
| 2021-03-31 | $7.93M 10-Q · filed 2022-05-10 | $485.22K 10-Q · filed 2021-05-24 |
| 2020-12-31 | $10.34M 8-K · filed 2023-01-10 | $846.07K 10-K · filed 2021-03-10 |
| 2020-09-30 | $12.28M 10-K · filed 2023-03-16 | $889.55K 10-Q · filed 2020-11-10 |
| 2020-06-30 | $13.16M 10-Q · filed 2021-08-16 | $1.02M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $1.09M 10-Q · filed 2021-05-24 | |
| 2019-12-31 | $1.31M 10-Q · filed 2021-05-24 | |
| 2019-09-30 | $22.29M 10-K · filed 2021-12-20 | $1.82M 10-Q · filed 2019-11-13 |
| 2019-05-23 | $0.00 10-K/A · filed 2021-05-07 | |
| 2018-09-30 | $33.53M 10-K · filed 2021-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |